Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ …

Background Coronavirus disease 2019 has emerged as a global pandemic causing millions
of critical cases and deaths. Early identification of at-risk patients is crucial for planning …

Abnormal immunological indicators associated with disease severity and mortality in
patients with COVID-19 have been reported in several observational studies. However …

Background and Objectives: Procalcitonin (PCT) is positively associated with the severity of
COVID-19 (including severe, critical, or fatal outcomes), but some of the confounding factors …

Abstract Mid Regional pro-ADM (MR-proADM) is a promising novel biomarker in the
evaluation of deteriorating patients and an emergent prognosis factor in patients with sepsis …

Adrenomedullin (AM) is a vasodilative peptide with various physiological functions,
including the maintenance of vascular tone and endothelial barrier function. AM levels are …

Coronavirus disease-19 (COVID-19) emerged late December 2019 in the city of Wuhan,
China and has since spread rapidly all over the world causing a global pandemic. While the …

Purpose We assessed the ability of mid-regional proadrenomedullin (MR-proADM) and C-
terminal proendothelin-1 (CT-proET-1) to predict 28-day mortality in critically ill patients with …

Objectives Thromboinflammation, resulting from a complex interaction between
thrombocytopathy, coagulopathy, and endotheliopathy, contributes to increased mortality in …

Background Mid-regional pro-adrenomedullin (MR-proADM) is useful for risk stratification in
patients with sepsis and respiratory infections. The study's purpose was to assess the …